Overexpression of PTPN21 promotes proliferation of EGF-stimulated acute lymphoblastic leukemia cells via the MAPK signaling pathways

References

• Terwilliger T, Abdul-Hay M. Acute lymphoblastic leukemia: a comprehensive review and 2017 update. Blood Cancer J. 2017;7(6):e577. doi:10.1038/bcj.2017.53
   PubMed Web of Science ®Google Scholar
• Gokbuget N, Dombret H, Ribera JM, et al. International reference analysis of outcomes in adults with B-precursor Ph-negative relapsed/refractory acute lymphoblastic leukemia. Haematologica. 2016;101(12):1524–1533. doi:10.3324/haematol.2016.144311
   PubMed Web of Science ®Google Scholar
• Toft N, Birgens H, Abrahamsson J, et al. Results of NOPHO ALL2008 treatment for patients aged 1-45 years with acute lymphoblastic leukemia. Leukemia. 2018;32(3):606–615. doi:10.1038/leu.2017.265
   PubMed Web of Science ®Google Scholar
• Mullighan CG, Goorha S, Radtke I, et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature. 2007;446(7137):758–764. doi:10.1038/nature05690
   PubMed Web of Science ®Google Scholar
• Roberts KG, Morin RD, Zhang J, et al. Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia. Cancer Cell. 2012;22(2):153–166. doi:10.1016/j.ccr.2012.06.005
   PubMed Web of Science ®Google Scholar
• Xiao H, Wang LM, Luo Y, et al. Mutations in epigenetic regulators are involved in acute lymphoblastic leukemia relapse following allogeneic hematopoietic stem cell transplantation. Oncotarget. 2016;7(3):2696–2708. doi:10.18632/oncotarget.6259
   PubMedGoogle Scholar
• Cardone L, Carlucci A, Affaitati A, et al. Mitochondrial AKAP121 binds and targets protein tyrosine phosphatase D1, a novel positive regulator of Src signaling. Mol Cell Biol. 2004;24(11):4613–4626. doi:10.1128/MCB.24.11.4613-4626.2004
   PubMed Web of Science ®Google Scholar
• Carlucci A, Gedressi C, Lignitto L, et al. Protein-tyrosine phosphatase PTPD1 regulates focal adhesion kinase autophosphorylation and cell migration. J Biol Chem. 2008;283(16):10919–10929. doi:10.1074/jbc.M707248200
   PubMed Web of Science ®Google Scholar
• Carlucci A, Porpora M, Garbi C, et al. PTPD1 supports receptor stability and mitogenic signaling in bladder cancer cells. J Biol Chem. 2010;285(50):39260–39270. doi:10.1074/jbc.M110.174706
   PubMed Web of Science ®Google Scholar
• Korff S, Woerner SM, Yuan YP, et al. Frameshift mutations in coding repeats of protein tyrosine phosphatase genes in colorectal tumors with microsatellite instability. BMC Cancer. 2008;8:329. doi:10.1186/1471-2407-8-329
   PubMed Web of Science ®Google Scholar
• Plani-Lam JH, Chow TC, Fan YH, et al. High expression of PTPN21 in B-cell non-Hodgkin's gastric lymphoma, a positive mediator of STAT5 activity. Blood Cancer J. 2016;6(1):e388. doi:10.1038/bcj.2015.107
   PubMedGoogle Scholar
• Wu ZZ, Lu HP, Chao CC. Identification and functional analysis of genes which confer resistance to cisplatin in tumor cells. Biochem Pharmacol. 2010;80(2):262–276. doi:10.1016/j.bcp.2010.03.029
   PubMed Web of Science ®Google Scholar
• Wang H, Zhu N, Ye X, et al. PTPN21-CDS(long) isoform inhibits the response of acute lymphoblastic leukemia cells to NK-mediated lysis via the KIR/HLA-I axis. J Cell Biochem. 2020;121(5-6):3298–3312. doi:10.1002/jcb.29601
   PubMed Web of Science ®Google Scholar
• Vermes I, Haanen C, Steffens-Nakken H, et al. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods. 1995;184(1):39–51. doi:10.1016/0022-1759(95)00072-I
   PubMed Web of Science ®Google Scholar
• Kim KH, Sederstrom JM. Assaying cell cycle status using flow cytometry. Curr Protoc Mol Biol. 2015;111:2861–2611. doi:10.1002/0471142727.mb2806s111
   Google Scholar
• Rahme R. Assaying cell cycle status using flow cytometry. Methods Mol Biol. 2021;2267:165–179. doi:10.1007/978-1-0716-1217-0_11
   PubMedGoogle Scholar
• Roskoski Jr. R. Src kinase regulation by phosphorylation and dephosphorylation. Biochem Biophys Res Commun. 2005;331(1):1–14. doi:10.1016/j.bbrc.2005.03.012
   PubMed Web of Science ®Google Scholar
• Moller NP, Moller KB, Lammers R, et al. Src kinase associates with a member of a distinct subfamily of protein-tyrosine phosphatases containing an Ezrin-like domain. Proc Natl Acad Sci U S A. 1994;91(16):7477–7481. doi:10.1073/pnas.91.16.7477
   PubMed Web of Science ®Google Scholar
• Sacco F, Boldt K, Calderone A, et al. Combining affinity proteomics and network context to identify new phosphatase substrates and adapters in growth pathways. Front Genet. 2014;5:115. doi:10.3389/fgene.2014.00115
   PubMed Web of Science ®Google Scholar
• Cho YC, Kim BR, Cho S. Protein tyrosine phosphatase PTPN21 acts as a negative regulator of ICAM-1 by dephosphorylating IKKbeta in TNF-alpha-stimulated human keratinocytes. BMB Rep. 2017;50(11):584–589. doi:10.5483/BMBRep.2017.50.11.169
   PubMed Web of Science ®Google Scholar
• Li XQ, Liu BC, Jiang XB, et al. Inhibition of PTPN21 has antitumor effects in glioma by restraining the EGFR/PI3 K/AKT pathway. Toxicol Appl Pharmacol. 2022;451:116180. doi:10.1016/j.taap.2022.116180
   PubMed Web of Science ®Google Scholar
• Chen L, Qian Z, Zheng Y, et al. Structural analysis of PTPN21 reveals a dominant-negative effect of the FERM domain on its phosphatase activity. Sci Adv. 2024;10(9):eadi7404. doi:10.1126/sciadv.adi7404
   PubMed Web of Science ®Google Scholar
• Sulic S, Panic L, Dikic I, et al. Deregulation of cell growth and malignant transformation. Croat Med J. 2005;46(4):622–638.
   PubMed Web of Science ®Google Scholar
• Dehm SM, Bonham K. Src gene expression in human cancer: the role of transcriptional activation. Biochem Cell Biol. 2004;82(2):263–274. doi:10.1139/o03-077
   PubMedGoogle Scholar
• De Grandis M, Bardin F, Fauriat C, et al. JAM-C Identifies Src Family Kinase-Activated Leukemia-Initiating Cells and Predicts Poor Prognosis in Acute Myeloid Leukemia. Cancer Res. 2017;77(23):6627–6640. doi:10.1158/0008-5472.CAN-17-1223
   PubMed Web of Science ®Google Scholar
• Fei X, Dou YN, Sun K, et al. TRIM22 promotes the proliferation of glioblastoma cells by activating MAPK signaling and accelerating the degradation of Raf-1. Exp Mol Med. 2023;55(6):1203–1217. doi:10.1038/s12276-023-01007-y
   PubMed Web of Science ®Google Scholar
• Gao Z, Zhao GS, Lv Y, et al. Anoikis-resistant human osteosarcoma cells display significant angiogenesis by activating the Src kinase-mediated MAPK pathway. Oncol Rep. 2019;41(1):235–245. doi:10.3892/or.2018.6827
   PubMed Web of Science ®Google Scholar
• Santarpia L, Lippman SM, El-Naggar AK. Targeting the MAPK-RAS-RAF signaling pathway in cancer therapy. Expert Opin Ther Targets. 2012;16(1):103–119. doi:10.1517/14728222.2011.645805
   PubMed Web of Science ®Google Scholar
• Huang Y, Thoms JA, Tursky ML, et al. MAPK/ERK2 phosphorylates ERG at serine 283 in leukemic cells and promotes stem cell signatures and cell proliferation. Leukemia. 2016;30(7):1552–1561. doi:10.1038/leu.2016.55
   PubMed Web of Science ®Google Scholar
• van der Zwet JCG, Buijs-Gladdines J, Cordo V, et al. MAPK-ERK is a central pathway in T-cell acute lymphoblastic leukemia that drives steroid resistance. Leukemia. 2021;35(12):3394–3405. doi:10.1038/s41375-021-01291-5
   PubMed Web of Science ®Google Scholar
• Morrison DK. MAP kinase pathways. Cold Spring Harb Perspect Biol. 2012;4(11):a011254. doi:10.1101/cshperspect.a011254
   PubMed Web of Science ®Google Scholar